AGL · agilon health, inc.

NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD

agilon health inc (AGL)

NEW YORK STOCK EXCHANGE, INC. Health Care
Move probability → Options chain →
$89.29 -2.37 (-2.59%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE $89.29
$89.29 $93.17
52-WEEK RANGE $89.29
$7.48 $133.04

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$1.53B
P/E (TTM1)—
EPS2 (TTM)$-14.06
Div Yield—
Beta33.12
Volume8,629
Open91.94
Prev Close91.66
Bid / Ask58.45 / 0.00
Next Earnings 2026-11-04

Analyst Recommendations

Strong buy 3 Buy 5 Hold 10 Sell 1 Strong sell 0

Aggregate ratings for 2026-10-01 (19 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
AGL +432.64%
vs S&P 500 +419.86%
1-YEAR RETURN
AGL +270.59%
vs S&P 500 +256.02%
6-MONTH RETURN
AGL +196.44%
3-MONTH RETURN
AGL -27.08%

Valuation Measures & Ratios

Enterprise Value4$1.45B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)0.26
Price / Book77.86
EV4 / Revenue0.25
EV4 / EBITDA—
Profit Margin-3.92%
Operating Margin-5.23%
Return on Equity (ROE8)-110.35%
Return on Assets (ROA9)-15.58%
Avg Volume (3M)288,980
Quarterly history (5 periods)
Measure Jun '26Mar '26Sep '25Jun '25Mar '25
Market cap $1.86B $131.4M — $945.0M $1.80B
P/E -12.60 -0.86 — -3.93 -12.63
Price/Sales 0.32 0.02 — 0.16 0.30
EV/Revenue 0.31 0.00 — 0.14 0.28
EV/EBITDA -8.78 -0.09 — — —
ROA -9.28% -10.20% — -14.04% -7.36%

Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).

Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short1,008,702
Change from Prior Settlement-3.99%
% of Float—
Days to Cover (Short Ratio)3.84

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Revenue $1.49B $1.42B $1.44B $1.39B $1.53B $1.45B $1.48B $1.60B
Operating income $11.8M $4.0M -$131.3M -$116.0M -$22.1M -$133.5M -$43.3M -$7.2M
Net income $18.0M $48.9M -$110.2M -$104.4M $12.1M -$117.6M -$30.7M -$6.1M
EPS (diluted) $1.04 $2.94 — $-6.31 $0.73 — — —
EPS (basic) $1.07 $2.95 — $-6.31 $0.73 — — —
Operating margin $1 $0 -$9 -$8 -$1 -$9 -$3 -$0

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $1.59B $1.50B $1.27B $1.60B $1.71B $1.93B $1.73B $2.09B
Total liabilities $1.36B $1.32B $1.14B $1.29B $1.30B $1.43B $1.26B $1.52B
Stockholders' equity — — — — — — $471.0M $574.9M
Total current assets $1.42B $1.32B $1.10B $1.34B $1.45B $1.65B $1.46B $1.81B
Total current liabilities $1.31B $1.27B $1.08B $1.24B $1.25B $1.37B $1.15B $1.41B
Cash & equivalents $107.2M $140.0M $173.7M $171.7M $171.4M $136.9M $188.2M $148.2M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$57.3M $23.7M -$20.5M -$18.2M -$35.1M -$32.0M $16.4M -$7.7M
Investing cash flow $19.9M $19.3M $22.6M $18.7M $70.5M -$23.1M $23.7M $46.6M
Financing cash flow $4.6M -$5.1M -$17.0K -$236.0K -$2.6M -$161.0K -$22.0K -$1.4M
Free cash flow -$60.7M $20.6M -$23.5M -$21.3M -$38.3M -$35.8M $13.2M -$11.2M
Capital expenditures $3.4M $3.1M $3.0M $3.2M $3.2M $3.8M $3.3M $3.5M
Depreciation & amortization $6.9M $6.8M $7.0M $7.4M $7.3M $6.9M $6.5M $6.2M

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding AGL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-02 to 2026-08-16

Recent transactions

  • Most recent: Gertsch Timothy (Chief Accounting Officer) — Tax withholding of 17 shares on 2026-08-16.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Gertsch TimothyChief Accounting OfficerTax withholding2026-08-1617
Zamore DeniseChief Legal OfficerTax withholding2026-08-0137
Schwaneke Jeffrey A.Chief Financial OfficerTax withholding2026-07-012,311
Wulf John WilliamDirectorGrant / award2026-06-022,133
WILLIAMS RONALD ADirectorGrant / award2026-06-022,133
McLoughlin KarenDirectorGrant / award2026-06-022,133
MCKENZIE DIANADirectorGrant / award2026-06-022,133
Mansukani SharadDirectorGrant / award2026-06-022,133
Battaglia SilvanaDirectorGrant / award2026-06-022,133
O'Rourke Timothy PatrickCEO & PresidentGrant / award2026-05-07120,000
Venkatachaliah GirishChief Technology OfficerTax withholding2026-04-15330
Shaker BenjaminChief Markets OfficerTax withholding2026-04-15571

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-08-16Gertsch TimothyChief Accounting OfficerTax withholding 17$96.90
2026-08-01Zamore DeniseChief Legal OfficerTax withholding 37$91.61
2026-07-01Schwaneke Jeffrey A.Chief Financial OfficerTax withholding 2,311$111.74
2026-06-02Wulf John WilliamDirectorGrant / award 2,133$0.00
2026-06-02WILLIAMS RONALD ADirectorGrant / award 2,133$0.00
2026-06-02McLoughlin KarenDirectorGrant / award 2,133$0.00
2026-06-02MCKENZIE DIANADirectorGrant / award 2,133$0.00
2026-06-02Mansukani SharadDirectorGrant / award 2,133$0.00
2026-06-02Battaglia SilvanaDirectorGrant / award 2,133$0.00
2026-06-01Zamore DeniseChief Legal OfficerTax withholding 485$92.54
2026-05-24Gertsch TimothyChief Accounting OfficerTax withholding 8$86.39
2026-05-07O'Rourke Timothy PatrickCEO & PresidentGrant / award 120,000$0.00
2026-05-07O'Rourke Timothy PatrickCEO & PresidentGrant / award 200,000$0.00
2026-04-15Zamore DeniseChief Legal OfficerTax withholding 220$26.88
2026-04-15Venkatachaliah GirishChief Technology OfficerTax withholding 330$26.88
2026-04-15Gertsch TimothyChief Accounting OfficerTax withholding 122$26.88
2026-04-15Shaker BenjaminChief Markets OfficerTax withholding 571$26.88
2026-04-14Zamore DeniseChief Legal OfficerTax withholding 20$22.68
2026-04-14Venkatachaliah GirishChief Technology OfficerTax withholding 96$22.68
2026-04-14Gertsch TimothyChief Accounting OfficerTax withholding 25$22.68
2026-04-14Shaker BenjaminChief Markets OfficerTax withholding 104$22.68
2026-04-01Schwaneke Jeffrey A.Chief Financial OfficerTax withholding 1,662$9.75
2026-04-01Schwaneke Jeffrey A.Chief Financial OfficerGrant / award 75,000$0.00
2026-04-01Shaker BenjaminChief Markets OfficerTax withholding 1,664$9.75
2026-04-01Shaker BenjaminChief Markets OfficerGrant / award 70,000$0.00
2026-04-01Gertsch TimothyChief Accounting OfficerTax withholding 266$9.75
2026-04-01Gertsch TimothyChief Accounting OfficerGrant / award 10,000$0.00
2026-04-01Venkatachaliah GirishChief Technology OfficerTax withholding 480$9.75
2026-04-01Venkatachaliah GirishChief Technology OfficerGrant / award 28,000$0.00
2026-04-01Zamore DeniseChief Legal OfficerTax withholding 1,024$9.75
2026-04-01Zamore DeniseChief Legal OfficerGrant / award 50,000$0.00
2026-03-09Zamore DeniseChief Legal OfficerOpen market purchase 5,535—
2026-03-09Zamore DeniseChief Legal OfficerTax withholding 2,056$0.60
2026-03-09Venkatachaliah GirishChief Technology OfficerOpen market purchase 18,448—
2026-03-09Venkatachaliah GirishChief Technology OfficerTax withholding 6,477$0.60
2026-03-09Shaker BenjaminChief Markets OfficerOpen market purchase 18,448—
2026-03-09Shaker BenjaminChief Markets OfficerTax withholding 6,348$0.60
2026-03-02Shaker BenjaminChief Markets OfficerOpen market purchase 500,000$0.60

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-22 08:37 UTC

FiledFormReport periodOfficial filing
2026-08-1842026-08-16 View on SEC.gov →
2026-08-0510-Q2026-06-30 View on SEC.gov →
2026-08-058-K2026-08-05 View on SEC.gov →
2026-08-0442026-08-01 View on SEC.gov →
2026-07-228-K2026-07-17 View on SEC.gov →
2026-07-0242026-07-01 View on SEC.gov →
2026-06-0542026-06-01 View on SEC.gov →
2026-06-0442026-06-02 View on SEC.gov →
2026-06-0442026-06-02 View on SEC.gov →
2026-06-0442026-06-02 View on SEC.gov →
2026-06-0442026-06-02 View on SEC.gov →
2026-06-0442026-06-02 View on SEC.gov →

Headlines about AGL (agilon health, inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist